These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 17122946)
1. Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis. Kapoor M; Rossor AM; Laura M; Reilly MM J Neuromuscul Dis; 2019; 6(2):189-199. PubMed ID: 30829617 [TBL] [Abstract][Full Text] [Related]
2. A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis. Casasnovas C; Lladó L; Borrachero C; Pérez-Santamaría PV; Muñoz-Beamud F; Losada-López IA; Baliellas-Comellas MC; González-Moreno J Ther Adv Neurol Disord; 2023; 16():17562864231191590. PubMed ID: 37655225 [TBL] [Abstract][Full Text] [Related]
3. Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations. Qin Q; Wei C; Piao Y; Lian F; Wu H; Zhou A; Wang F; Zuo X; Han Y; Lyu J; Guo D; Jia J Neurologist; 2021 Sep; 26(5):189-195. PubMed ID: 34491937 [TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature. Carberry N; Yu S; Fayerman RN; Dugue R; Miller M; Tanji K; Goyal T; Canoll P; Brannagan TH Neurohospitalist; 2023 Jan; 13(1):90-95. PubMed ID: 36531853 [TBL] [Abstract][Full Text] [Related]
5. In vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis. Batista AR; Flotte TR Mol Ther; 2021 Sep; 29(9):2633-2634. PubMed ID: 34433081 [No Abstract] [Full Text] [Related]
6. Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation. Suzuki Y; Tasaki M; Kakisaka K; Nishiya M; Nomura T; Nakao M; Sugawara E; Takikawa Y; Ueda M Amyloid; 2024 Sep; 31(3):232-234. PubMed ID: 38444123 [No Abstract] [Full Text] [Related]
7. Reply: Liver transplantation in transthyretin amyloidosis: Issues and challenges. Rocha A; Lobato L Liver Transpl; 2015 Apr; ():. PubMed ID: 25891323 [No Abstract] [Full Text] [Related]
9. Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry. Suhr OB; Larsson M; Ericzon BG; Wilczek HE; Transplantation; 2016 Feb; 100(2):373-81. PubMed ID: 26656838 [TBL] [Abstract][Full Text] [Related]
10. Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis. Azevedo EP; Ledo JH; Barbosa G; Sobrinho M; Diniz L; Fonseca AC; Gomes F; Romão L; Lima FR; Palhano FL; Ferreira ST; Foguel D Cell Death Dis; 2013 Sep; 4(9):e789. PubMed ID: 24008733 [TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants. Holmgren G; Hellman U; Anan I; Lundgren HE; Jonasson J; Stafberg C; Fahoum S; Suhr OB Amyloid; 2005 Sep; 12(3):184-8. PubMed ID: 16194874 [TBL] [Abstract][Full Text] [Related]
12. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738 [TBL] [Abstract][Full Text] [Related]
14. Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis. De Carolis P; Galeotti M; Ficarra G; Masetti M; Grimaldi D; Cortelli P Neurol Sci; 2006 Nov; 27(5):352-4. PubMed ID: 17122946 [TBL] [Abstract][Full Text] [Related]